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Abstract. The influence of in vivo melatonin administration on in vitro
pituitary follicle stimulating hormone (FSH), growth hormone (GH) and
prolactin secretion, as well as the possible influence of dopamine (DA) were
evaluated in prepubertal (31-day-old), pubertal (33-day-old) and adult female
rats at diestrus phase of the sexual cycle. The in vitro pituitary hormone
secretions were evaluated at basal rate for the first hour of incubation only, in
Krebs Ringer phosphate (KRP) (I1) and after a second hour of incubation with
KRP (I2) or with KRP+DA (I2 plus DA). I1PRL secretion was significantly
higher in 33-day-old control and melatonin treated (MEL) rats as compared to
I2 periods. However, in 31-day-old rats I1 secretion was higher than in the I2 or
I2+DA periods, in MEL rats. In vitro GH secretion was significantly higher at I1
than during I2 periods in the control 31- and 33-day-old groups, but not in
MEL rats. The only significant effect of DA was the elevation of GH in
prepubertal MEL rats. In vitro FSH release was increased by melatonin in
31-and 33-day-old female rats. No differences in PRL, GH and FSH secretion
were found in adult rats. In conclusion, the results show that melatonin effects
upon in vitro pituitary gland activity are reproductive-stage-dependent
modifying the secretory capacity of the lactotrop, gonadotrop and somatotrop
during prepubertal and pubertal ages but not in adult rats studied at a quiescent
phase of the sexual cycle.
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INTRODUCTION
The pineal gland through its main hormone melatonin
is involved in the modulation of reproductive activity in
seasonal breeding mammals (Bittman et al. 1985,
Hastings 1989, Misztal et al. 1996). By contrast, the in-
fluence of melatonin in reproduction of nonseasonal
breeders is unclear (Arendt 1998). A major question that
remains unresolved is the level of the neuroendocrine-
-reproductive axis at which melatonin has its effects.
While the hypothalamus was considered initially to be
the most likely site of this action, the discovery of a
prominent population of melatonin receptors in the pars
tuberalis of the anterior pituitary of the rat focused atten-
tion on this structure (Vanecek 1988, Willians 1989,
Weaver and Reppert 1990). Several studies in the litera-
ture reflect the effect of melatonin on in-vitro secretion
of pituitary hormones. Thus previous workers (Jetton et
al. 1994) found that exposure of pituitary tissue from
Golden hamster (Mesocricetus auratus) to melatonin us-
ing perfusion techniques, decreased the basal secretion
of luteinizing hormone (LH) but did not affect the stimu-
lated release of LH or follicle stimulating hormone
(FSH) by gonadotropin releasing hormone (GnRH), re-
gardless of the daily period of pituitary dissection. Other
authors (Rozell and Mead 1993) showed that melatonin
had no effect on pituitary response to GnRH and failed to
inhibit prolactin secretion during a 48h culture period
from pituitary of the seasonal breeding Spotted skunk
(Spilogale pygmaea). However melatonin significantly
reduced the inhibitory effects of dopamine (DA) on
prolactin secretion.
Prolactin, FSH, and growth hormone (GH) are pitu-
itary hormones implicated in reproductive function.
FSH stimulates follicular development and estradiol
synthesis (Leung and Amstrong 1980). GH administra-
tion to female hypophysectomized rats increased the
esteroidogenic response to FSH in vitro, whereas re-
duced serum GH levels in intact rats produced a dimin-
ished ovary response to gonadotropins (Davoren and
Hsueh 1986). In addition, delayed puberty in humans as-
sociated with a GH deficit, was reversed after GH ther-
apy (Tresguerres 1995).
In the present work, we examined the possible direct
effect of melatonin treatment on in-vitro pituitary gland
hormones (FSH, GH, prolactin) secretion. This study
was performed at three different reproductive phases,
prepubertal, pubertal and adulthood in order to investi-
gate possible age dependent changes. Having in mind
that hypothalamic dopaminergic pathways have been
considered as one pausible mechanism by which
melatonin can act on the neuroendocrine-reproductive
system (Tortonese and Lincoln 1995, Zisapel et al.
1995), the influence of DA on in vitro pituitary hor-
mone (FSH,GH and prolactin) release was also studied.
METHODS
Experimental animals
Female Wistar rats from our colony were used. The
animals were housed in a 12 h light/dark cycle (light on
at 08.00 h) and at an ambient temperature of approxi-
mately 23
o
C, with standard rat chow and water ad libi-
tum. According to Ojeda et al’s classification (1980)
concerning postnatal sexual maturation, the infantile pe-
riod extends from 8 to 21 days, the juvenile or
prepubertal from 21 to 32 and the pubertal from day 32 to
the day of vaginal opening. Studies of female rats were
started at either infantile, 20-day-old (n = 48), or adult,
60-day-old (n = 28). Female rats were submitted to
melatonin or placebo treatment until different ages stud-
ied.
Melatonin administration
Melatonin was dissolved in absolute ethanol and di-
luted in 0.9% NaCl to a dose of 150 g/100g BW.
Melatonin was given s.c. 1,5 h before the end of the light
phase, taking into account previous findings (Tamarkin
et al. 1976). Both the melatonin (Sigma M-2550, Chemi-
cal Co, St. Louis, Mo) and vehicle solutions were made
up fresh each day. Melatonin treatment started on day 20
and extended through the prepubertal period to day 31 (n
= 12) or 33 (n = 10). In adults, melatonin treatment
started at 60 days of age (n = 15) and was administrated
for one month and then until first diestrus was observed.
Control prepubertal (n = 12), pubertal (n = 14) and adult
(n = 13) rats received only vehicle solution. Only rats not
showing vaginal opening at 31 and 33 days of age were
used in this study.
Pituitary incubations
The day after the end of the treatment period, animals
were decapitated at 10 am. The in situ anterior pituitaries
were removed, immediately dissected and divided in
two halves to be used to analyze the gland functional ac-
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tivity at two incubation periods: Basal rate release (I1),
the first hour of incubation, and the second incubation
period (I2), the second hour of incubation. The effect of
DA, (Sigma H-8502 hydroxytyramine), (10
-7
M), on the
release of prolactin, GH and FSH was investigated.
Hemipituitaries were placed in incubation tubes contain-
ing 1 ml of Krebs-Ringer phosphate (KRP) medium.
They were incubated in a Haake SWD 20 bath at 37ºC,
shaking at 60 cycles/ min, and were gassed with 95% O2 :
5% CO2. After 30 min, the medium was removed and
discarded, and 1 ml of fresh medium was added. An hour
later the medium (I1) was removed and saved for mea-
surements of the basal rate of hormone secretion during
the 30-90 minute long first incubation period. It was then
replaced with another 1 ml of KRP medium (I2) or 1 ml of
KRP plus DA (I2+DA). One hour later, during the subse-
quent 90-150 minutes of incubation, the assay was
ended. Both media I2 and I2+DA (second incubation peri-
ods) were removed and kept frozen for later measure-
ment of hormones.
Hormone determinations
Hormones were measured by RIA employing second
antibody facilitated separation with reagents kindly do-
nated by the National Institute of Health (NIADD,
Bethesda, MD). The assays were carried out as previ-
ously described (Esquifino et al. 1989a, Moreno et al.
1995). Values of prolactin were expressed as
ng/hemipituitary/h of rat prolactin RP-3. The final dilu-
tion of anti-rat prolactin S-9 was 1:430.000. Values of
FSH were expressed as ng/hemipituitary/h of rat
FSH-RP-3. The final dilution of anti-rat FSH was
1:125.000. Values of GH were expressed as ng/hemipitu-
itary/h of rat GH RP-3. The final dilution of anti-rat GH
was 1:1.500.000. All samples were measured in the same
assay in order to avoid interassay variation.
Statistical analysis
Statistical analysis was performed using the Sigma
Statistics Program (Copyright Horus Hardware 1986).
Results were expressed as mean ± SEM (Standard Error
of the mean). Comparisons between groups at each incu-
bation period studied, as well as among incubation times
in the same group, were made by one-way analysis of
variance (ANOVA). Individual comparisons were then
made by Neuman-Keuls multirange test.
RESULTS
In vitro pituitary prolactin secretion
Basal prolactin release (I1) increased from 31- to
33-day-old in to adult rats in both control and melatonin
treated rats (Fig. 1). In 31-day-old melatonin treated rats,
Fig 1. In vitro PRL secretion from the
hemipituitaries of saline (Control) and
melatonin treated (MEL) prepubertal
(31 days), pubertal (33 days) and adult
female rats. The concentration of PRL
was determined in the medium col-
lected from 30-90 min of incubation
(Incub-1), and 90-150 min of incuba-
tion performed in the absence
(Incub-2) or presence (Incub-2-DA) of
10
-7
M dopamine. Results are expressed
as mean  SEM values of 8 to 15 inde-
pendent incubations. The differences
between the control and corresponding
melatonin treated groups are indicated
by asterisks: *, P<0.01; **,P<0.05; the
differences from basal secretion within
the group are indicated by letters: a,
P<0.01; b, P<0.05.
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basal secretion rate without (I2) and with DA addition
(I2+DA) showed significantly increased (P<0.05) in vitro
prolactin release as compared to control rats. However,
in 33-day-old female rats, basal prolactin release was
higher in control than in melatonin treated rats, although
the differences were not significant. Prolactin release at
both I2 and I2+DA incubation periods in 31-day-old con-
trol rats and 33-day-old control and melatonin treated
rats, was significantly reduced (P<0.01, P<0.05) as com-
pared to the basal incubation period (I1). No significant
differences were observed in adult rats at the diestrus
phase between groups or incubation periods.
In vitro pituitary GH secretion
The results obtained for GH secretion rate (Fig. 2)
were similar to those obtained for prolactin since basal
GH release (I1) increased from 31 to 33 days of age and in
adult rats. In 31- and 33-day-old control rats, GH release
was significantly reduced (p<0.01; p<0.05) at both I2 and
I2+DA incubation periods as compared to the basal (I1) se-
cretion rate. For 31-day-old melatonin treated rats, GH
release after DA addition (I2+DA) was significantly higher
(P<0.05) when compared to control rats. At 33 days of
age melatonin treated rats’ basal GH release was signifi-
cantly lower (P<0.05) than that at the control group. No
differences between groups or among incubation periods
were observed in adult rats.
In vitro pituitary FSH secretion
In 31-day-old melatonin treated rats FSH release at
both basal (I1) and second incubation periods (I2 and
I2+DA) (Fig. 3) showed significantly increased values
(P<0.01) in comparison to control rats. In 33-day-old
melatonin treated rats significantly higher in vitro FSH
release was only observed at the basal rate (I1) as com-
pared to the control group. Lack of an effect of melatonin
on in vitroFSH secretion in adult aged rats at the diestrus
phase of the sexual cycle was observed. Contrary to re-
sults obtained for prolactin and GH release in
prepubertal female rats, in vitro FSH release was not
modified by the addition of DA (10
-7
M) to the incubation
medium (I2+DA), when compared to basal release (I1).
DISCUSSION
The results of this investigation clearly establish that
pituitary prolactin release increased from prepubertal to
adult age in both groups studied. Increased in vitro
prolactin secretion with age is in agreement with previ-
ous data reported in plasma of female rats (Advis et al.
1981, Esquifino et al. 1989a, Moreno et al. 1995). In vi-
tro prolactin secretion was more marked in 31-day-old
melatonin treated rats than in controls. This difference
disappeared in 33-day-old rats. This suggests that during
the prepubertal period in vivo melatonin administration
Fig 2. In vitro GH secretion from the
hemipituitaries of saline (Control) and
melatonin treated (MEL) prepubertal
(31 days), pubertal (33 days) and adult
female rats. The concentration of GH
was determined in the medium col-
lected from 30-90 min of incubation
(Incub-1), and 90-150 min of incuba-
tion performed in the absence
(Incub-2) or presence (Incub-2-DA) of
10
-7
M dopamine. Results are ex-
pressed as mean  SEM values of 8 to
15 independent incubations. The dif-
ferences between the control and cor-
responding melatonin treated groups
are indicated by asterisks: *, P<0.01;
**, P<0.05; the differences from basal
secretion within the group are indi-
cated by letters: a, P<0.01; b, P<0.05.
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slightly modifies the in vitro secretory capacity of the
lactotroph. This is in agreement with the well known
effect of this hormone on lactotroph activity (Waldhauser
et al. 1987, Esquifino et al. 1989b). In pubertal 33-day-old
female rats, as a consequence of higher basal secretion
rates, prolactin secretion seem to decrease at second in-
cubation periods, but not in 31-day-old control rats when
basal prolactin secretion rate was lower. As this effect
was not observed in adult rats, the results obtained dur-
ing pubertal age suggest that when all the mechanism re-
quired for prolactin secretion are maturating, the
stimulatory mechanism of prolactin is more active than
the inhibitory, since prolactin secretion decreased a simi-
lar amount at the second incubation time independently
of whether DA was added or not to the incubation media.
The higher prolactin secretion observed in adult rats at
all incubation periods are indicative of a pituitary gland
in a consolidated hormonal stage. Lack of an effect of
melatonin on these in vitropituitary gland secretion rates
are in agreement with results obtained from in vivo stud-
ies performed in adult female rats (Villanúa et al. 1989).
The results obtained for the in vitro GH secretion rates
were similar to those observed for prolactin, since GH
secretion rates increased from prepubertal to adult rats.
This increase was blunted when melatonin treatment was
extended until the prepubertal phase at 33 days of age. In
this way, in blind or normal rats kept in constant dark-
ness, in which melatonin secretion is increased, reduced
pituitary GH content was found (Smythe and Lazarus
1973). However, this antisomatotropic activity of
melatonin is controversial, and a facilitatory role of
melatonin on basal GH release has been suggested at the
hypothalamic level (Valcavi et al. 1993). The addition of
DA to the incubation media did not result in reduced GH
release from in vitro pituitary as was previously found
(Hirasawa and Kamada 1992, Tuomisto and Mannisto,
1985, Moreno et al. 1995), but our results show that pitu-
itaries from prepubertal rats primed with melatonin re-
lease far more GH than those from controls when DA
were added to the respective media. This indicates a syn-
ergistic action of melatonin and DA only at this stage of
sexual maturation. The reduced amounts of basal GH se-
cretion observed in pituitaries from pubertal melatonin
treated rats and the lack of an inhibitory effect at both the
I2 and I2+DA incubation periods, contrary to what was ob-
served in the control group, suggest a direct effect of
melatonin on the somatotrophs. However melatonin ex-
erted differential effects on both in vitro GH and
prolactin secretory mechanisms depending on the sexual
maturation of the female rats. No differences were ob-
served in GH in vitro secretion from adult pituitaries of
control and melatonin-treated groups. Similar effects
depending of the age of animals were previously ob-
served when the effect of cyclosporine treatment on in
vitro prolactin and GH release was investigated (Moreno
et al. 1995).
Fig 3. In vitro FSH secretion from the
hemipituitaries of saline (Control) and
melatonin treated (MEL) prepubertal
(31 days), pubertal (33 days) and adult
female rats. The concentration of FSH
was determined in the medium col-
lected from 30-90 min of incubation
(Incub-1), and 90-150 min of incuba-
tion performed in the absence
(Incub-2), or presence (Incub-2-DA),
of 10
-7
M dopamine. Results are ex-
pressed as mean  SEM values of 7 to
14 independent incubations. The dif-
ferences between the control and cor-
responding melatonin treated groups
are indicated by asterisks: *, P<0.01;
**, P<0.05; the differences from basal
secretion within the group are indi-
cated by letters: a, P<0.01; b, P<0.05.
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The results concerning FSH indicated that in vivo
melatonin treatment modified basal in vitro FSH release
in prepubertal and pubertal female rats. The observed in-
fluence of melatonin on in vitro pituitary FSH release
disappeared in adult rats, at the diestrus phase, coincid-
ing with previous results (Esquifino et al. 1989). This
suggests that melatonin exerts modulatory effects at the
pituitary level mainly in immature rats as was previously
shown (Martin and Sttaler 1982). Opposite to what was
observed for in vitro GH or prolactin release in
prepubertal and pubertal female rats, pituitary in vitro
FSH release was not decreased at the second incubation
period independently of DA addition to the incubation
media. It was previously found in rat studies that DA
alone was able to suppress in vitro basal hemipituitary
LH and FSH release when relatively high concentrations
(30, 60 and 90 mol/L) of DA were used (Karanth et al.
1992). The lack of a DA effect on in vitro FSH release
may also be interpreted from the point of view that
gonadotrop cells separated from normal hypothalamic
control became unresponsive to external stimuli as was
found for in vitro pituitary-hypothalamic interactions
and the importance of their intact neural connections
(Dutt et al. 1986).
An age dependency of melatonin treatment on in vitro
pituitary gland hormone secretory capacity is deduced.
During prepubertal and pubertal age secretions were in-
fluenced by melatonin, but no influence was observed in
adult rats, at the diestrus or quiescent phase of the sexual
cycle.
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